Kissei Pharmaceutical Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1946-08-09
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.kissei.co.jp
Long-term Study of KAD-1229 in Type 2 Diabetes Patients
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT01333592
- Locations
- 🇯🇵
Japan, Kanto region, Chugoku region, Kyushu region, Japan
A Comparative Study of KSO-0400 in BPH Patients With LUTS
Phase 2
Completed
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2011-07-04
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT01222650
- Locations
- 🇯🇵
Japan, Kanto region, Japan
A Study of KCT-0809 in Patients With Dry Eye Syndromes
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2011-07-04
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT01211951
- Locations
- 🇯🇵
Japan, Tohoku, Kanto, Chubu, Kansai, Kyushu region, Japan
A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2010-09-28
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01004016
- Locations
- 🇯🇵
Japan, Japan, Japan
A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder
Phase 3
Completed
- Conditions
- Overactive Bladder
- Interventions
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2010-07-27
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 750
- Registration Number
- NCT01004315
- Locations
- 🇯🇵
Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan
Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2010-07-27
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT01003405
- Locations
- 🇯🇵
Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan
Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00863538
- Locations
- 🇯🇵
Japan, Kanto Region, Japan
A Phase II Study of KUC-7483 in Patients With Overactive Bladder
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2009-09-04
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT00742833
- Locations
- 🇯🇵
Japan, Tohoku region, Japan
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2009-03-18
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT00721656
- Locations
- 🇯🇵
Japan, Shikoku region, Japan
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2008-10-21
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 291
- Registration Number
- NCT00461617
© Copyright 2025. All Rights Reserved by MedPath